Ser203 as well as Ser204 and Ser207 in fifth transmembrane domain of the human β2‐adrenoceptor contributes to agonist binding and receptor activation
暂无分享,去创建一个
T. Nagao | H. Kurose | T Nagao | H Kurose | T Sato | H Kobayashi | Hiroyuki Kobayashi | Takayuki Sato
[1] C. Strader,et al. Identification of residues required for ligand binding to the beta-adrenergic receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[2] D. Perez,et al. The Unique Nature of the Serine Interactions for -Adrenergic Receptor Agonist Binding and Activation (*) , 1996, The Journal of Biological Chemistry.
[3] C. Fraser,et al. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. , 1991, Molecular pharmacology.
[4] H. Kikkawa,et al. Differential contribution of two serine residues of wild type and constitutively active β2‐adrenoceptors to the interaction with β2‐selective agonists , 1997, British journal of pharmacology.
[5] S. Nagata,et al. pEF-BOS, a powerful mammalian expression vector. , 1990, Nucleic acids research.
[6] K. Neve,et al. Contributions of Conserved Serine Residues to the Interactions of Ligands with Dopamine D2 Receptors , 1992, Journal of neurochemistry.
[7] N. Pollock,et al. Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation. , 1992, The Journal of biological chemistry.
[8] F. Fanelli,et al. Amino acids of the α 1B‐adrenergic receptor involved in agonist binding: differences in docking catecholamines to receptor subtypes , 1996, FEBS letters.
[9] C. Strader,et al. Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. , 1989, The Journal of biological chemistry.
[10] C. Strader,et al. Structural features required for ligand binding to the beta‐adrenergic receptor. , 1987, The EMBO journal.
[11] H. Kikkawa,et al. The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005. , 1998, Molecular pharmacology.